| Secondary |
| Cardiac Failure |
20.0% |
| Hypertension |
11.5% |
| Conjunctivitis |
10.0% |
| Hyperuricaemia |
10.0% |
| Incontinence |
10.0% |
| Thrombosis Prophylaxis |
10.0% |
| Drug Use For Unknown Indication |
6.9% |
| Pain |
6.9% |
| Supplementation Therapy |
4.6% |
| Product Used For Unknown Indication |
3.1% |
| Thrombophlebitis |
2.3% |
| Diabetes Mellitus |
1.5% |
| Deep Vein Thrombosis |
0.8% |
| Device Therapy |
0.8% |
| Epilepsy |
0.8% |
| Pulmonary Embolism |
0.8% |
|
| Stevens-johnson Syndrome |
52.9% |
| Vein Disorder |
11.8% |
| General Physical Health Deterioration |
5.9% |
| Hypertensive Crisis |
5.9% |
| Hypoalbuminaemia |
5.9% |
| Multi-organ Failure |
5.9% |
| Tachycardia |
5.9% |
| Visual Impairment |
5.9% |
|
| Concomitant |
| Hypertension |
30.4% |
| Product Used For Unknown Indication |
21.1% |
| Drug Use For Unknown Indication |
18.8% |
| Hyperparathyroidism Secondary |
4.2% |
| Renal Transplant |
3.6% |
| Coronary Artery Disease |
2.6% |
| Diabetes Mellitus |
2.6% |
| Blood Phosphorus Increased |
1.7% |
| Pain |
1.5% |
| Dyspepsia |
1.4% |
| Metastatic Renal Cell Carcinoma |
1.4% |
| Osteoporosis |
1.4% |
| Rectal Cancer |
1.4% |
| Breast Cancer Metastatic |
1.3% |
| Cardiac Failure |
1.3% |
| Prophylaxis |
1.3% |
| Peripheral Arterial Occlusive Disease |
1.1% |
| Chronic Myeloid Leukaemia |
1.0% |
| Renal Failure |
1.0% |
| Restless Legs Syndrome |
1.0% |
|
| Vomiting |
10.9% |
| Cerebrovascular Accident |
9.4% |
| Alveolitis |
7.8% |
| Hypertension |
6.3% |
| Urinary Tract Infection |
6.3% |
| Urine Output Decreased |
6.3% |
| Arterial Occlusive Disease |
4.7% |
| Blood Pressure Increased |
4.7% |
| Implantable Defibrillator Insertion |
4.7% |
| Syncope |
4.7% |
| Toe Amputation |
4.7% |
| Wound Infection |
4.7% |
| Blood Potassium Decreased |
3.1% |
| Blood Pressure Systolic Increased |
3.1% |
| Cytomegalovirus Infection |
3.1% |
| Diarrhoea |
3.1% |
| Gangrene |
3.1% |
| Gastric Haemorrhage |
3.1% |
| Haemoglobin Decreased |
3.1% |
| Haemorrhage |
3.1% |
|
| Interacting |
| Hypertension |
40.0% |
| Type 2 Diabetes Mellitus |
20.0% |
| Hyperlipidaemia |
10.0% |
| Hyperuricaemia |
10.0% |
| Osteoporosis Prophylaxis |
10.0% |
| Prophylaxis |
10.0% |
|
| Circulatory Collapse |
100.0% |
|
